Seer to Present at the Cowen 43rd Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq:SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston, MA.
Related news for (SEER)
- Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
- Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
- SpaceWorks Enterprises Inc. Integrates AI into Spaceflight Planning and National Defense Initiatives with SEERai, Galorath’s AI-Powered Cost Estimation Platform
- Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
- SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY